Application 212429
- Type
- ANDA
- Sponsor
- AUROLIFE PHARMA LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXYCODONE HYDROCHLORIDE | OXYCODONE HYDROCHLORIDE | SOLUTION;ORAL | 5MG/5ML | No | No |
| 002 | OXYCODONE HYDROCHLORIDE | OXYCODONE HYDROCHLORIDE | SOLUTION;ORAL | 100MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212429-001 | OXYCODONE HYDROCHLORIDE | OXYCODONE HYDROCHLORIDE | 5MG/5ML | SOLUTION / ORAL | 2020-01-27 | ||
| A212429-002 | OXYCODONE HYDROCHLORIDE | OXYCODONE HYDROCHLORIDE | 100MG/5ML | SOLUTION / ORAL | 2020-01-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A212429-001 | OXYCODONE HYDROCHLORIDE | 5MG/5ML | SOLUTION / ORAL | 2020-01-27 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A212429-002 | OXYCODONE HYDROCHLORIDE | 100MG/5ML | SOLUTION / ORAL | 2020-01-27 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxycodone Hydrochloride Oral Solution | OXYCODONE HYDROCHLORIDE ORAL SOLUTION | Aurolife Pharma, LLC | 0b3fa92e-8351-4401-860d-4bba8a7155e6 | 2024-01-18 | Boxed warning, Warnings, Adverse reactions | 212429 ANDA212429 13107-262 13107-261 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 13107-261 | Oxycodone Hydrochloride Oral Solution | Oxycodone Hydrochloride Oral Solution | Aurolife Pharma, LLC | ANDA | Current |
| 13107-262 | Oxycodone Hydrochloride Oral Solution | Oxycodone Hydrochloride Oral Solution | Aurolife Pharma, LLC | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 76470 | ORIG | 2023-11-07 |